Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Ann Neurol. 2016 Apr 27;79(6):929–939. doi: 10.1002/ana.24647

Table 2.

Descriptive statistics of WMH volume (in cm3), including median, first quartile (Q1), third quartile (Q3), and interquartile range for tight bands of participants defined by estimated years to symptom onset and stratified by mutation status.

Mutation non-carrier Mutation carrier Total

EYO N Med Q1 Q3 IQR N Med Q1 Q3 IQR N Med Q1 Q3 IQR
−30 to −20 y 13 0.19 0.04 0.44 0.40 18 0.41 0.19 0.72 0.54 31 0.24 0.04 0.72 0.68
−20 to −10 y 40 0.35 0.05 0.79 0.74 52 0.29 0.05 0.81 0.76 92 0.34 0.05 0.80 0.75
−10 to 0 y 36 0.23 0.05 0.75 0.70 73 0.37 0.09 1.01 0.91 109 0.32 0.05 0.97 0.92
0 to 10 y 15 0.08 0.00 0.36 0.36 35 0.43 0.00 1.93 1.93 50 0.29 0.00 1.10 1.10
10 to 21 y 11 0.27 0.00 0.48 0.48 6 0.55 0.13 2.12 1.99 17 0.27 0.10 0.51 0.41

Total 115 0.24 0.04 0.66 0.62 184 0.37 0.07 0.97 0.90 299 0.31 0.05 0.89 0.84